Sign Up Today and Learn More About Chronicled Stock
Invest in or calculate the value of your shares in Chronicled or other pre-IPO companies through EquityZen's platform.
Chronicled Stock
Chronicled builds trust and automation in the life science industry, powered by blockchain.
About Chronicled Stock
Founded
2014
Headquarters
San Francisco, CA, US
Industries
Chronicled builds trust and automation in the life science industry, powered by blockchain. Based in San Francisco, Chronicled is the custodian of MediLedger, the primary blockchain-based network in the healthcare and life science industry that powers solutions to facilitate trust and automation between companies. Chronicled develops solutions for revenue management and supply chain on the MediLedger Network.
Chronicled Press Mentions
Stay in the know about the latest news on Chronicled
NABP Acquires Patient Safety Tool From Chronicled, Inc.
morningstar • Jun 14, 2023
Vantage Solutions and Chronicled Join to Enhance QU4RTET Platform with MediLedger VRS Capabilities
prnewswire • Jul 12, 2022
AmerisourceBergen Partners with Chronicled to Optimize Pharmaceutical Chargeback Accuracy Using Blockchain-Powered Technology
biospace • Apr 22, 2022
How to Build a Blockchain App: All-in-One Tech and Business Guide [2022]
addevice • Apr 12, 2022
Chronicled, a Web3-powered network within the life sciences industry receives US$8.3 million funding from True Global Ventures, who is backing for the first time a female founder
prn • Feb 19, 2022
Chronicled Management
Leadership team at Chronicled
Co-Founder
Ryan Orr
CTO and Co-Founder
Maurizio Greco
Join now and verify your accreditation status to gain access to:
- Chronicled current valuation
- Chronicled stock price
- Available deals in Chronicled and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Chronicled stock?
Accredited investors can buy pre-IPO stock in companies like Chronicled through EquityZen funds. These investments are made available by existing Chronicled shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Chronicled stock?
Shareholders can sell their Chronicled stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
